SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001640334-23-002255
Filing Date
2023-11-30
Accepted
2023-11-30 16:14:31
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1 lxrp_s1.htm S-1 184031
2 OPINION lxrp_ex51.htm EX-5.1 6869
3 CONSENT lxrp_ex231.htm EX-23.1 2223
4 CONSENT lxrp_ex232.htm EX-23.2 3141
5 FEE TABLE lxrp_ex107.htm EX-FILING FEES 14500
6 lxrp_s1img2.jpg GRAPHIC 14676
7 lxrp_s1img1.jpg GRAPHIC 14676
8 lxrp_ex232img4.jpg GRAPHIC 8547
9 lxrp_ex51img2.jpg GRAPHIC 7058
10 lxrp_ex232img3.jpg GRAPHIC 8546
  Complete submission text file 0001640334-23-002255.txt   286200
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-1 | Act: 33 | File No.: 333-275810 | Film No.: 231456011
SIC: 2834 Pharmaceutical Preparations